Afuco™ Anti-ITGAL ADCC Therapeutic Antibody (Odulimomab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CD11a. Odulimomab is an investigational drug for the prevention of transplant rejection and for the treatment of various immunological diseases. It is a mouse monoclonal antibody directed against the alpha chain of the protein lymphocyte function-associated antigen 1 which is involved in immune reactions.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-108 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | ITGAL |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | Neut, ELISA, IF, IP, FuncS, FC |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |